Corcept Therapeutics, Inc. (CORT)
87.11
+1.80
(+2.11%)
USD |
NASDAQ |
Dec 11, 16:00
87.95
+0.84
(+0.96%)
After-Hours: 20:00
Corcept Therapeutics Free Cash Flow: 162.57M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Amgen, Inc. | 11.54B |
| Gilead Sciences, Inc. | 9.162B |
| LeMaitre Vascular, Inc. | 66.23M |
| United Therapeutics Corp. | 1.116B |
| Vertex Pharmaceuticals, Inc. | 3.337B |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 54.48M |
| Cash from Investing (Quarterly) | 14.64M |
| Cash from Financing (Quarterly) | -46.41M |
| Free Cash Flow Per Share (Quarterly) | 0.4561 |
| Free Cash Flow to Equity (Quarterly) | 54.73M |
| Free Cash Flow to Firm (Quarterly) | 54.48M |
| Free Cash Flow Yield | 1.56% |